Article info

Download PDFPDF
Audit, research and guideline update
Essential medicines for COPD and asthma in low and middle-income countries

Authors

  • Yaser T Bazargani Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Anthonious de Boer Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Hubert G M Leufkens Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Aukje K Mantel-Teeuwisse Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Aukje K Mantel-Teeuwisse, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, PO Box 80082, 3508 TB Utrecht, The Netherlands; A.K.Mantel{at}uu.nl
View Full Text

Citation

Bazargani YT, de Boer A, Leufkens HGM, et al
Essential medicines for COPD and asthma in low and middle-income countries

Publication history

  • Received February 5, 2014
  • Accepted February 6, 2014
  • First published March 3, 2014.
Online issue publication 
September 01, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.